Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (236) 236
Publication (58) 58
Book / eBook (31) 31
Newspaper Article (9) 9
Book Chapter (3) 3
Dissertation (3) 3
Book Review (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (141) 141
index medicus (95) 95
female (80) 80
male (78) 78
middle aged (69) 69
adult (66) 66
hematology (65) 65
transplantation (58) 58
article (53) 53
aged (47) 47
oncology (39) 39
animals (36) 36
immunology (36) 36
adolescent (33) 33
hematology, oncology and palliative medicine (32) 32
cancer (31) 31
mice (27) 27
hematopoietic stem cells (25) 25
treatment outcome (24) 24
research (23) 23
child (22) 22
abridged index medicus (21) 21
transplantation, homologous (21) 21
risk factors (20) 20
young adult (19) 19
bone-marrow-transplantation (18) 18
therapy (18) 18
bone marrow transplantation (16) 16
cell line, tumor (16) 16
hematopoietic stem cell transplantation (16) 16
analysis (15) 15
care and treatment (15) 15
time factors (15) 15
antineoplastic combined chemotherapy protocols - therapeutic use (14) 14
disease-free survival (14) 14
immunotherapy (14) 14
recurrence (14) 14
stem cells (14) 14
cardiac & cardiovascular systems (13) 13
follow-up studies (13) 13
health aspects (13) 13
hemic and lymphatic diseases (13) 13
medicine, research & experimental (13) 13
whole-body irradiation (13) 13
aged, 80 and over (12) 12
cd8-positive t-lymphocytes - immunology (12) 12
disease (12) 12
leukemia (12) 12
mice, inbred c57bl (12) 12
total-body irradiation (12) 12
acute myeloid-leukemia (11) 11
cyclophosphamide (11) 11
genetics & heredity (11) 11
hematopoietic stem cell transplantation - methods (11) 11
prevention (11) 11
prognosis (11) 11
survival rate (11) 11
t cells (11) 11
transplantation conditioning - methods (11) 11
bone-marrow (10) 10
chemotherapy (10) 10
child, preschool (10) 10
clinical trials (10) 10
combined modality therapy (10) 10
diagnosis (10) 10
genetic aspects (10) 10
lymphoma (10) 10
medical research (10) 10
medicine, general & internal (10) 10
mortality (10) 10
retrospective studies (10) 10
risk (10) 10
united states (10) 10
acute lymphoblastic-leukemia (9) 9
bone marrow (9) 9
genetics (9) 9
graft vs host disease - prevention & control (9) 9
hematopoietic stem cell transplantation - adverse effects (9) 9
in-vivo (9) 9
infant (9) 9
internal medicine (9) 9
lymphocytes (9) 9
patient outcomes (9) 9
patients (9) 9
studies (9) 9
transplantation, autologous (9) 9
versus-host-disease (9) 9
antineoplastic combined chemotherapy protocols - adverse effects (8) 8
drug therapy (8) 8
expression (8) 8
flow cytometry (8) 8
gene expression (8) 8
graft vs host disease - etiology (8) 8
hematologic malignancies (8) 8
hematologic neoplasms - therapy (8) 8
leukemia, myeloid, acute - therapy (8) 8
methotrexate (8) 8
mice, inbred balb c (8) 8
mice, knockout (8) 8
mice, scid (8) 8
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (18) 18
UTL at Downsview - May be requested (8) 8
Gerstein Science - Stacks (5) 5
UofT at Mississauga - Stacks (4) 4
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Online Resources - Online (3) 3
Regis College - Stacks (2) 2
St. Michael's College (John M. Kelly) - 3rd Floor (2) 2
UofT at Scarborough - Stacks (2) 2
Engineering & Comp. Sci. - Stacks (1) 1
Knox College (Caven) - Stacks (1) 1
OISE - Stacks (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
UofT at Mississauga - Reference (1) 1
Victoria University E.J. Pratt - Storage (1) 1
Victoria University Emmanuel College - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs
by Tefferi, Ayalew, MD and Kantarjian, Hagop, MD and Rajkumar, S. Vincent, MD and Baker, Lawrence H., DO and Abkowitz, Jan L., MD and Adamson, John W., MD and Advani, Ranjana Hira, MD and Allison, James, MD and Antman, Karen H., MD and Bast, Robert C., MD and Bennett, John M., MD and Benz, Edward J., MD and Berliner, Nancy, MD and Bertino, Joseph, MD and Bhatia, Ravi, MD and Bhatia, Smita, MD and Bhojwani, Deepa, MD and Blanke, Charles D., MD and Bloomfield, Clara D., MD and Bosserman, Linda, MD and Broxmeyer, Hal E., PhD and Byrd, John C., MD and Cabanillas, Fernando, MD and Canellos, George Peter, MD and Chabner, Bruce A., MD and Chanan-Khan, Asher, MD and Cheson, Bruce, MD and Clarkson, Bayard, MD and Cohn, Susan L., MD and Colon-Otero, Gerardo, MD and Cortes, Jorge, MD and Coutre, Steven, MD and Cristofanilli, Massimo, MD and Curran, Walter J., MD and Daley, George Q., MD, PhD and DeAngelo, Daniel J., MD, PhD and Deeg, H. Joachim, MD and Einhorn, Lawrence H., MD and Erba, Harry P., MD, PhD and Esteva, Francisco J., MD, PhD and Estey, Elihu, MD and Fidler, Isaiah J., DVM, PhD and Foran, James, MD and Forman, Stephen, MD and Freireich, Emil, MD and Fuchs, Charles, MD, MPH and George, James N., MD and Gertz, Morie A., MD and Giralt, Sergio, MD and Golomb, Harvey, MD and Greenberg, Peter, MD and Gutterman, Jordan, MD and Handin, Robert I., MD and Hellman, Samuel, MD and Hoff, Paulo Marcelo, MD and Hoffman, Ronald, MD and Hong, Waun Ki, MD and Horowitz, Mary, MD, MS and Hortobagyi, Gabriel N., MD and Hudis, Clifford, MD and Issa, Jean Pierre, MD and Johnson, Bruce Evan, MD and Kantoff, Philip W., MD and Kaushansky, Kenneth, MD and Khayat, David, MD, PhD and Khuri, Fadlo R., MD and Kipps, Thomas J., MD, PhD and Kripke, Margaret, PhD and Kyle, Robert A., MD and Larson, Richard A., MD and Lawrence, Theodore S., MD, PhD and Levine, Ross, MD and Link, Michael P., MD and Lippman, Scott M., MD and Lonial, Sagar, MD and Lyman, Gary H., MD, MPH and Markman, Maurie, MD and Mendelsohn, John, MD and Meropol, Neal J., MD and Messinger, Yoav, MD and Mulvey, Therese M., MD and O’Brien, Susan, MD and Perez-Soler, Roman, MD and Pollock, Raphael, MD, PhD and Prchal, Josef, MD and Press, Oliver, MD, PhD and Radich, Jerald, MD and Rai, Kanti, MD and Rosenberg, Saul A., MD and Rowe, Jacob M., MD and Rugo, Hope, MD and Runowicz, Carolyn D., MD and Sandmaier, Brenda M., MD and Saven, Alan, MD and Schafer, Andrew I., MD and Schiffer, Charles, MD and Sekeres, Mikkael A., MD, MS and Silver, Richard T., MD and Siu, Lillian L., MD and Steensma, David P., MD and ...
Mayo Clinic Proceedings, ISSN 0025-6196, 2015, Volume 90, Issue 8, pp. 996 - 1000
Internal Medicine | MEDICINE, GENERAL & INTERNAL | Drug Costs | United States - epidemiology | Neoplasms - economics | Humans | Patient Participation | Patient Advocacy | Antineoplastic Agents - economics | Neoplasms - epidemiology | Prescription Fees | Neoplasms - drug therapy | Antimitotic agents | Cancer patients | Patient outcomes | Economic aspects | Dosage and administration | Drug therapy | Antineoplastic agents
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Karl Georg Blume, MD
by Forman, Stephen J and Negrin, Robert and Chao, Nelson
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2013, Volume 19, Issue 6, pp. 845 - 846
Hematology, Oncology and Palliative Medicine
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
by Topp, Max S, Dr and Gökbuget, Nicola, MD and Stein, Anthony S, MD and Zugmaier, Gerhard, MD and O'Brien, Susan, MD and Bargou, Ralf C, Prof and Dombret, Hervé, MD and Fielding, Adele K, PhD and Heffner, Leonard, MD and Larson, Richard A, Prof and Neumann, Svenja, MD and Foà, Robin, MD and Litzow, Mark, Prof and Ribera, Josep-Maria, Prof and Rambaldi, Alessandro, MD and Schiller, Gary, MD and Brüggemann, Monika, MD and Horst, Heinz A, MD and Holland, Chris, MS and Jia, Catherine, PhD and Maniar, Tapan, MD and Huber, Birgit, PhD and Nagorsen, Dirk, MD and Forman, Stephen J, MD and Kantarjian, Hagop M, Prof
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 1, pp. 57 - 66
Summary Background Adults with relapsed or refractory B-precursor acute lymphoblastic leukaemia have an unfavourable prognosis. Blinatumomab is a bispecific... 
Hematology, Oncology and Palliative Medicine | CELL-ENGAGING ANTIBODY | SALVAGE | SURVIVAL | TRIALS | THERAPY | ONCOLOGY | INOTUZUMAB OZOGAMICIN | ACUTE LYMPHOCYTIC-LEUKEMIA | T-CELLS | CHEMOTHERAPY | CHAIN ANTIBODY CONSTRUCT | Recurrence | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - pathology | Age Factors | United States | Humans | Middle Aged | Salvage Therapy | Drug Resistance, Neoplasm | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Young Adult | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Time Factors | Antineoplastic Agents - adverse effects | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - mortality | Antibodies, Bispecific - administration & dosage | Adult | Female | Drug Administration Schedule | Europe | Kaplan-Meier Estimate | Hematopoietic Stem Cell Transplantation | Treatment Outcome | Remission Induction | Antibodies, Bispecific - therapeutic use | Disease-Free Survival | Antibodies, Bispecific - adverse effects | Adolescent | Intention to Treat Analysis | Aged | Infusions, Intravenous | T cells | Adults | Safety and security measures
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Dose Escalation of Total Marrow Irradiation With Concurrent Chemotherapy in Patients With Advanced Acute Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation
by Wong, Jeffrey Y.C., MD and Forman, Stephen, MD and Somlo, George, MD and Rosenthal, Joseph, MD and Liu, An, PhD and Schultheiss, Timothy, PhD and Radany, Eric, MD, PhD and Palmer, Joycelynne, PhD and Stein, Anthony, MD
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2013, Volume 85, Issue 1, pp. 148 - 156
Purpose We have demonstrated that toxicities are acceptable with total marrow irradiation (TMI) at 16 Gy without chemotherapy or TMI at 12 Gy and the reduced... 
Radiology | Hematology, Oncology and Palliative Medicine | TOTAL-BODY IRRADIATION | MULTIPLE-MYELOMA | ETOPOSIDE | ONCOLOGY | CYCLOPHOSPHAMIDE | BONE-MARROW | RANDOMIZED-TRIAL | EXPERIENCE | GUIDED TOTAL-MARROW | HELICAL TOMOTHERAPY | REGIMENS | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Organs at Risk - radiation effects | Recurrence | Cyclophosphamide - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Liver - radiation effects | Male | Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality | Bone Marrow - radiation effects | Busulfan - administration & dosage | Cyclophosphamide - adverse effects | Transplantation, Homologous | Whole-Body Irradiation - adverse effects | Young Adult | Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy | Liver - drug effects | Adult | Female | Transplantation Conditioning - adverse effects | Transplantation Conditioning - methods | Leukemia, Myeloid, Acute - therapy | Radiotherapy Dosage | Busulfan - adverse effects | Etoposide - adverse effects | Induction Chemotherapy - methods | Hematopoietic Stem Cell Transplantation | Etoposide - administration & dosage | Combined Modality Therapy - adverse effects | Stomatitis - etiology | Leukemia, Myeloid, Acute - mortality | Whole-Body Irradiation - methods | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Combined Modality Therapy - methods | Bone marrow | Chemotherapy | Transplantation | Nuclear radiation | Hematopoietic stem cells | Cancer | Index Medicus | IRRADIATION | PATIENTS | HEALTH HAZARDS | MYLERAN | FAILURES | STANDARDS | RADIOLOGY AND NUCLEAR MEDICINE | BONE MARROW | ENDOXAN | RADIATION DOSES | TOXICITY | LEUKEMIA | total marrow irradiation | tomotherapy | total body irradiation | bone marrow transplantation | acute leukemia
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Next Generation Sequencing in Adult B Cell Acute Lymphoblastic Leukemia Patients
by Torra, Olga Sala, MD and Othus, Megan, PhD and Williamson, David W., PhD and Wood, Brent, MD, PhD and Kirsch, Ilan, MD and Robins, Harlan, PhD and Beppu, Lan, BS and O'Donnell, Margaret R., MD and Forman, Stephen J., MD and Appelbaum, Frederick R., MD and Radich, Jerald P., MD
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2017, Volume 23, Issue 4, pp. 691 - 696
Highlights • NGS of IgH VDJ in adult ALL is an accurate and sensitive measure of MRD. • Patients MRD negative by NGS and MFC have superior outcome vs. cases... 
Hematology, Oncology and Palliative Medicine | Acute lymphoblastic leukemia | Minimal residual disease | GENE REARRANGEMENTS | BONE-MARROW | PERIPHERAL-BLOOD | IMMUNOLOGY | CHRONIC MYELOID-LEUKEMIA | CHILDREN | TRANSPLANTATION | HIGH-RISK | DIAGNOSED CHRONIC PHASE | FLOW-CYTOMETRY | HEMATOLOGY | MRD | Humans | Middle Aged | Precursor Cell Lymphoblastic Leukemia-Lymphoma - diagnosis | Immunoglobulins - genetics | Neoplasm, Residual - genetics | Peripheral Blood Stem Cells - pathology | Young Adult | Flow Cytometry | Bone Marrow - pathology | Neoplasm, Residual - diagnosis | Adolescent | Adult | B-Lymphocytes - pathology | High-Throughput Nucleotide Sequencing - methods | Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology | Blood | Medical examination | Acute lymphocytic leukemia | Oncology, Experimental | Analysis | Research | Cancer | minimal residual disease
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Outcome of Patients with Recurrent or Refractory Lymphoma Undegoing Myeloablative Allogeneic HCT Using BEAM Conditioning with Tacrolimus/Sirolimus Based Gvhd Prophylaxis
by Salhotra, Amandeep, MD and Mei, Matthew, MD and Stiller, Tracey, M.S and Thomas, Sandra, Ph.D and Palmer, Joycelynne, PhD and Thai, Cao, MD and Zain, Jasmine, MD and Parker, Pablo M., MD and Popplewell, Leslie, MD, FACP and Chen, Robert, MD and Budde, Lihua E., MD, PhD and Nademanee, Auayporn, MD and Forman, Stephen J., MD and Nakamura, Ryotaro, MD
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2016, Volume 22, Issue 3, pp. S227 - S227
Hematology, Oncology and Palliative Medicine | Health maintenance organizations | Relapse | Lymphomas | Patient outcomes | Diseases
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Outcomes of Hematopoietic Stem Cell Transplantation (HSCT) Among Adults with Relapsed/Refractory (r/r) Acute Lymphoblastic Leukemia (ALL) Achieving Remission with Blinatumomab
by Stein, Anthony S., MD and Topp, Max S., MD and Gokbuget, Nicola, MD and Bargou, Ralf C., MD and Dombret, Hervé, MD, PhD and Larson, Richard A., MD and Rambaldi, Alessandro, MD and Schiller, Gary J., MD and Zugmaier, Gerhard, MD and Sterling, Lulu, PhD and Benjamin, Jonathan, MD, PhD and Kantarjian, Hagop, MD and Forman, Stephen J., MD
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2016, Volume 22, Issue 3, pp. S35 - S36
Hematology, Oncology and Palliative Medicine
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text HyperCVAD Chemotherapy in Mantle Cell Lymphoma Patients is Associated with Higher Rates of Hematopoietic Progenitor Cell Mobilization Failure, Despite Plerixafor Rescue
by Salhotra, Amandeep, MD and Shan, Yuan, MD and Tsai, Ni-Chun, MS and Sanchez, James F., PhD and Aldoss, Ibrahim, MD and Ali, Haris, MD and Paris, Tanya, BA and Spielberger, Ricardo, MD and Cao, Thai M., MD and Nademanee, Auayporn, MD and Forman, Stephen J., MD and Chen, Robert, MD
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2017
Highlights • In the post-plerixafor era, R-hyperCVAD was associated with higher rates of collection failures. • Plerixafor does not overcome the negative... 
Hematology, Oncology and Palliative Medicine
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Tacrolimus/Sirolimus (T/S)-Based GvHD Prophylaxis Does Not Overcome Poor Outcome of HLA Mismatch after Unrelated Donor (URD) Peripheral Blood Stem Cell Transplantation
by Al Malki, Monzr M., MD and Gendzekhadze, Ketevan, PhD and Karanes, Chatchada, MD and Dagis, Andy and Palmer, Joycelynne, PhD and Pham, Anh, MD and Parker, Pablo, MD and Senitzer, David, PhD and Nademanee, Auayporn, MD and Forman, Stephen J., MD and Nakamura, Ryotaro, MD
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2016, Volume 22, Issue 3, pp. S419 - S419
Hematology, Oncology and Palliative Medicine | Transplantation | Hematopoietic stem cells | Stem cells
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Does Adding Zevalin® to Reduced Intensity Regimen (RIC) of Fludarabine and Melphalan Improve Outcome of Patients with Relapsed/Refractory B-Cell Lymphoma Who Were Chemoresistant and FDG PET Positive at the Time of Allo-HCT?
by Nademanee, Auayporn, MD and Raubitschek, Andrew, MD and Stiller, Tracey, M.S and Simpson, Jennifer, B.S and Palmer, Joycelynne, PhD and Cai, Jilian, MD, PhD and Sahebi, Firoozeh, MD and Popplewell, Leslie, MD, FACP and Chen, Robert, MD and Forman, Stephen J., MD
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2016, Volume 22, Issue 3, pp. S341 - S342
Hematology, Oncology and Palliative Medicine | Health maintenance organizations | Care and treatment | PET imaging | Patient outcomes | Immunotherapy | Melphalan | Lymphomas | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Experience with Faculty Supervision of an Electronic Resident Sign-out System
by Nabors, Christopher, MD, PhD and Peterson, Stephen J., MD and Lee, Wei-Nchih, MD, MPH and Mumtaz, Arif, MD and Shah, Tushar, MD and Sule, Sachin, MD and Gutwein, Andrew H., MD and Forman, Leanne, MD and Eskridge, Etta, MD and Wold, Eric, MD, MS and Stallings, Gary W., MD, MPH and Burak, Kathleen Kelly, MD and Karmen, Carol, MD and Behar, Caren F., MD and Carosella, Christine, MD and Yu, Shick, MD and Kar, Kausik, MD and Gennarelli, Melissa, MD and Bailey-Wallace, Gail, MD and Goldberg, Randy, MD and Guo, Gary, MD, PhD and Frishman, William H., MD
American Journal of Medicine, The, ISSN 0002-9343, 2010, Volume 123, Issue 4, pp. 376 - 381
Internal Medicine | PATIENT-CARE | INTERNS | MEDICINE, GENERAL & INTERNAL | IMPACT | INFORMATION | HOUSE STAFF | COMMUNICATION FAILURES | Continuity of Patient Care - organization & administration | Patient Transfer - methods | Faculty, Medical | Internship and Residency | Humans | Education, Medical - standards | Medical Records Systems, Computerized - standards | Continuity of Patient Care - standards | Medical Errors - prevention & control | Medical Records Systems, Computerized - organization & administration
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Phase II Study of Yttrium-90 Ibritumomab Tiuxetan Plus High Dose BEAM for Non-Hodgkin Lymphoma: the Role of Histology
by Krishnan, Amrita Y., MD and Palmer, Joycelynne, PhD and Nademanee, Auayporn P., MD and Chen, Robert, MD and Popplewell, Leslie L., MD and Tsai, Ni-Chun, MS and Sanchez, James F., PhD and Simpson, Jennifer, BA, CCRP and Spielberger, Ricardo, MD and Yamauchi, Dave, MD and Forman, Stephen J., MD
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2017, Volume 23, Issue 6, pp. 922 - 929
Highlights • The Z-BEAM conditioning regimen for autoHCT is potentially effective in DLBCL. • Non-relapse mortality rates are low, with little short- or... 
Hematology, Oncology and Palliative Medicine | BEAM | 90yttrium-ibritumomab tiuxetan | radioimmunotherapy | Zevalin | autologous stem cell transplantation
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Impact of Donor Activating KIR2DS5 and KIR2DS2 on Outcome of Allogeneic Hematopoietic Cell Transplantation (AlloHCT) in Patients with Acute Myeloid Leukemia (AML)
by Gendzekhadze, Ketevan, PhD and Al Malki, Monzr M., MD and Nakamura, Ryotaro, MD and Marcucci, Guido, MD and Dagis, Andy and Palmer, Joycelynne, PhD and Nademanee, Auayporn, MD and Forman, Stephen J., MD and Senitzer, David, PhD
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2016, Volume 22, Issue 3, pp. S34 - S35
Hematology, Oncology and Palliative Medicine | Transplantation | Hematopoietic stem cells
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Deleterious Effect of High-Expression HLA-DPB1 Allele Mismatch in Patients (pts) Undergoing 10/10 Match Unrelated Donor (MUD) Hematopoietic Cell Transplant (HCT) for Hematological Malignancies
by Al Malki, Monzr M., MD and Gendzekhadze, Ketevan, PhD and Dagis, Andy and Palmer, Joycelynne, PhD and Karanes, Chatchada, MD and Parker, Pablo, MD and Senitzer, David, PhD and Forman, Stephen J., MD and Nademanee, Auayporn, MD
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2016, Volume 22, Issue 3, pp. S71 - S72
Hematology, Oncology and Palliative Medicine
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Extramedullary Relapse Following Total Marrow and Lymphoid Irradiation in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation
by Kim, Ji Hyun, MD and Stein, Anthony, MD and Tsai, Nicole, MS and Schultheiss, Timothy E., PhD and Palmer, Joycelynne, PhD and Liu, An, PhD and Rosenthal, Joseph, MD and Forman, Stephen J., MD and Wong, Jeffrey Y.C., MD
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2014, Volume 89, Issue 1, pp. 75 - 81
Purpose Approximately 5% to 20% of patients who undergo total body irradiation (TBI) in preparation for hematopoietic cell transplantation (HCT) can develop... 
Radiology | Hematology, Oncology and Palliative Medicine | RISK-FACTORS | ONCOLOGY | ACUTE MYELOGENOUS LEUKEMIA | BONE-MARROW | RANDOMIZED-TRIAL | ACUTE MYELOID-LEUKEMIA | GUIDED TOTAL-MARROW | HELICAL TOMOTHERAPY | VERSUS-HOST-DISEASE | HEMATOLOGIC MALIGNANCIES | MYELODYSPLASTIC SYNDROME | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Recurrence | Prospective Studies | Age Factors | Humans | Middle Aged | Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality | Antineoplastic Agents - therapeutic use | Bone Marrow - radiation effects | Melphalan - therapeutic use | Organs at Risk | Hematopoietic Stem Cell Transplantation - mortality | Cyclophosphamide - therapeutic use | Whole-Body Irradiation - adverse effects | Young Adult | Myelodysplastic Syndromes - therapy | Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy | Antineoplastic Agents - adverse effects | Blast Crisis - mortality | Hematopoietic Stem Cell Transplantation - adverse effects | Organ Sparing Treatments - adverse effects | Adult | Transplantation Conditioning - adverse effects | Lymphatic Irradiation - adverse effects | Transplantation Conditioning - methods | Child | Leukemia, Myeloid, Acute - therapy | Lymphatic Irradiation - methods | Radiotherapy Dosage | Busulfan - therapeutic use | Etoposide - therapeutic use | Vidarabine - analogs & derivatives | Vidarabine - therapeutic use | Blast Crisis - therapy | Leukemia, Myeloid, Acute - mortality | Whole-Body Irradiation - methods | Adolescent | Myelodysplastic Syndromes - mortality | Graft vs Host Disease - prevention & control | Aged | Hematopoietic Stem Cell Transplantation - methods | Bone marrow | Relapse | Transplantation | Nuclear radiation | Hematopoietic stem cells | Diseases | PATIENTS | WHOLE-BODY IRRADIATION | LYMPH NODES | BONE MARROW | RADIATION DOSES | TESTES | COMPARATIVE EVALUATIONS | COMPUTERIZED TOMOGRAPHY | CT-GUIDED RADIOTHERAPY | SKELETON | SPLEEN | LIVER | RADIOLOGY AND NUCLEAR MEDICINE | SKIN | BRAIN
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text Hematopoietic Stem-Cell Contribution to Ectopic Skeletogenesis
by Kaplan, Frederick S., MD and Glaser, David L., MD and Shore, Eileen M., PhD and Pignolo, Robert J., MD, PhD and Xu, Meiqi, BS and Zhang, Yi, MD, PhD and Emerson, Stephen G., MD, PhD and Senitzer, David, PhD and Forman, Stephen J., MD
Journal of Bone and Joint Surgery, ISSN 0021-9355, 2007, Volume 89, Issue 2, pp. 347 - 357
Background Fibrodysplasia ossificans progressiva is a rare genetic disorder of ectopic skeletogenesis associated with dysregulation of bone morphogenetic... 
Orthopedics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
17. Full Text Phenotypic and Functional Characteristics of NK Cells Associated with CMV Infection after Allogeneic Hematopoietic Stem Cell Transplantation (HCT)
by Nakamura, Ryotaro, MD and Zaia, John A., MD and Forman, Stephen J., MD and Gallez-hawkins, Ghislaine and Franck, Anne and Jeannet, Laetitia and Li, Xiuli and Dagis, Andy and Behrendt, Carolyn, PhD
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2016, Volume 22, Issue 3, pp. S154 - S155
Hematology, Oncology and Palliative Medicine | Cytomegalovirus infections | Killer cells | Transplantation | Health aspects | Hematopoietic stem cells | Stem cells
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
18. Full Text Preliminary Data from a Multi-Center Study of Clofarabine / Busulfan Conditioning for Acute Myeloid Leukemia Not in Remission at Allogeneic Transplantation
by Magenau, John, M.D and Westervelt, Peter, MD, PhD and McGuirk, Joseph P., DO and Khaled, Samer K., MBBCh, MD and Becker, Pamela S and Jagasia, Madan H., MD, MBBS, MS and Rowley, Scott, MD and Kim, Dennis and Frey, Noelle V and Parameswaran, Hari, MD and Lieland, Stefanie and Braun, Thomas, PhD and Schechter-Finkelstein, Tal, MD and Parkin, Brian, MD and Harris, Andrew C., M.D and Lee Scott, Bart, MD and DiPersio, John F., MD, PhD and Forman, Stephen J., MD and Mineishi, Shin, MD
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2014, Volume 20, Issue 2, pp. S155 - S156
Hematology, Oncology and Palliative Medicine
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
19. Full Text Comparison of Outcomes in Patients Aged <75, 75 to 84, and ≥85 Years With ST-Elevation Myocardial Infarction (from the ACTION Registry-GWTG)
by Forman, Daniel E., MD and Chen, Anita Y., MS and Wiviott, Stephen D., MD and Wang, Tracy Y., MD, MHS and Magid, David J., MD, MPH and Alexander, Karen P., MD
American Journal of Cardiology, The, ISSN 0002-9149, 2010, Volume 106, Issue 10, pp. 1382 - 1388
ST-segment elevation myocardial infarction (STEMI) is common in older adults and has high age-related mortality. We describe contemporary STEMI care using the... 
Cardiovascular | CARDIAC & CARDIOVASCULAR SYSTEMS | QUALITY IMPROVEMENT | ACUTE CORONARY SYNDROMES | REPERFUSION THERAPY | IN-HOSPITAL MORTALITY | HEALTH-CARE PROFESSIONALS | THROMBOLYTIC THERAPY | SCIENTIFIC STATEMENT | PRIMARY ANGIOPLASTY | GERIATRIC-CARDIOLOGY | HEART-ASSOCIATION COUNCIL | Myocardial Infarction - surgery | Myocardial Reperfusion | Humans | Middle Aged | Aged, 80 and over | Female | Male | Myocardial Infarction - physiopathology | Registries | Treatment Outcome | Aged
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
20. Full Text Phenotypic and Functional Characteristics of NK Cells Associated with Cytomegalovirus (CMV) Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation (HCT)
by Nakamura, Ryotaro, MD and Franck, Anne and Gallez-hawkins, Ghislaine and Jeannet, Laetitia and Li, Xiuli and Forman, Stephen J., MD and Zaia, John A., MD
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2014, Volume 20, Issue 2, pp. S145 - S145
Hematology, Oncology and Palliative Medicine
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.